The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent mandate. Hims pushed back against the accusation.
Popular weight loss drugs promise to slim waistlines and improve our general health, but they also come with some unpleasant side effects involving our face, mouth, and teeth.
Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
New research finds that ER visits related to semaglutide use might be on the rise.
Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose weight—without the nauseating symptoms now commonly seen with GLP-1 drugs.
People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the average weight loss seen with semaglutide.
Scientists have developed a gel-based version of semaglutide that could reduce how often people need to take it.
GLP-1 drugs are effective weight loss tools, but exactly how they work is still mysterious.
Case Western Reserve University researchers have found early evidence that semaglutide can temper nicotine cravings.
New research has found a link between semaglutide and improved brain health in people with type 2 diabetes.
Semaglutide doesn't work for everyone and can have side effects, but a study in mice may point to a solution.
New research suggests GLP-1 drugs like Ozempic can help prevent up to 10 different obesity-related cancers in people with type 2 diabetes.
New research has found a potential link between semaglutide use and a rare eye condition called NAION, though more work is needed to prove causation.
Dozens of obesity and diabetes treatments are in the pipeline, some of which may help people lose even more weight than existing drugs like semaglutide.
The UN agency has received reports of medication falsified to look like the diabetes and weight loss drug Ozempic in at least 3 countries, including the U.S.
Experts with the U.S. Preventive Services Task Force say not enough data has been collected to know whether newer obesity medications for teens are safe.
Americans pay $969 a month for Ozempic, while Canadians pay just $155.
Critics claim that drugs like semaglutide and other GLP-1s can dangerously sap away our muscle mass, but what does the current science actually tell us?
Plus: Marines test Mycenean armor, an explosive SpaceX engine test, the link between stomach paralysis and Ozempic, and more.
